FreeTender
Accepting bidstenderGermany

Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zu dem Wirkstoff Epoetin alfa/ zeta (ATC B03XA01)

Conclusion of a non-exclusive discount agreement according to § 130a para 8 SGB V on the active substance Epoetin alfa/ zeta (ATC B03XA01)English, machine translated

Issued by GWQ ServicePlus AG · via Bekanntmachungsservice — Germany (federal notices)

Published
27 Oct 2026
Closes
19 Oct 2028, 08:00 UTC
Reference
Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den Wirkstoffen Etanercept (ATC L04AB01) und Epoetin alfa/zeta (ATC B03XA01)
Location
DEA11, Germany
Sector
Healthcare & Pharma
Type
goods

At a glance

GWQ ServicePlus AG in Germany has published a tender in healthcare & pharma: “Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zu dem Wirkstoff Epoetin alfa/ zeta (ATC B03XA01)”. Submissions close on 19 October 2028, 723 days from today. Quote reference Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den Wirkstoffen Etanercept (ATC L04AB01) und Epoetin alfa/zeta (ATC B03XA01) in any correspondence with the buyer. FreeTender has recorded 18 notices from this buyer since 2026, 18 of them currently open. There are 830 open healthcare & pharma notices in Germany on FreeTender. Bids are submitted to the buyer through Bekanntmachungsservice — Germany (federal notices), not through FreeTender.

English summary

Machine translated from German by FreeTender. The original notice below is the binding text.

Part of: Conclusion of non-exclusive discount agreements according to § 130a para 8 SGB V on the active substances etanercept (ATC L04AB01) and epoetin alfa/zeta (ATC B03XA01). Contracting authority: GWQ ServicePlus AG Lot: LOT-0002. CPV code: 33600000. Place of performance: DEA11. Published: 27 October 2026. Deadline for receipt of tenders: 19 October 2028 10:00. Published on the German federal notice service (announcement service, oeffentlichevergabe.de); the full notice and documents are on the source page.

Details

Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zu dem Wirkstoff Epoetin alfa/ zeta (ATC B03XA01) Part of: Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den Wirkstoffen Etanercept (ATC L04AB01) und Epoetin alfa/zeta (ATC B03XA01).

Contracting authority: GWQ ServicePlus AG.

Lot: LOT-0002.

CPV code: 33600000.

Place of performance: DEA11.

Published: 27 October 2026.

Deadline for receipt of tenders: 19 October 2028 10:00.

Published on the German federal notice service (Bekanntmachungsservice, oeffentlichevergabe.de); the full notice and documents are on the source page.

Context for bidders

We hold 18 notices from GWQ ServicePlus AG, going back to August 2026 — 18 of them still open. There are 830 open Healthcare & Pharma tenders in Germany. This one closes in 723 days.

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.

  • Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
  • Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
  • Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
  • Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
  • Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
  • Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.

More Healthcare & Pharma tenders

All Healthcare & Pharma tenders →

FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.

Verify & apply on the official portal →